ÒÑÈëפСľ³æ 74 Ìì
http://www.iprexmed.com/
°ÐµãÔ¤²â/ÐéÄâɸѡ/»¯Ñ§ÐÅϢѧϵͳ/Êý¾Ý¿â
¹ã¶«Ê¡¹ãÖÝÊÐÌìºÓÇøÁúâù·91ºÅ5015ÊÒ
ÁªÏµÈË: ´Þ¹¤ / ÓÊÏä: sales@iprexmed.com / QQ: 2277165792 / µç»°: 020-87565003 / ÊÖ»ú: 18928913950£¨Î¢ÐÅ£©
²é¿´: 3029  |  »Ø¸´: 129
¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß kspm20225 µÄ 58 ¸ö½ð±Ò £¬»ØÌû¾ÍÁ¢¼´»ñµÃ 1 ¸ö½ð±Ò£¬Ã¿ÈËÓÐ 1 ´Î»ú»á
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

kspm20225

ÖÁ×ðľ³æ (ÕýʽдÊÖ)

[É̼ҹ©Ó¦] µ±ÐéÄâɸѡÓöÉϸßͨÁ¿É¸Ñ¡

±¾É̼ÒûÓвμÓÓŻݻ£¬Ò»ÆðÑûÇëËûÀ´²Î¼Ó°É ÎҵĴú½ðȯ

´ú½ðȯ0Ôª
ÏÞÁ¿ x ÕÅ
Âú x ¿ÉʹÓã»ÓÐЧÆÚ x Ì죻¹ýÆÚ¿ÉÍË

ÄÚÈÝ

Ò©Îïɸѡ¹ÜÀíϵͳ
Ò©Îïɸѡ¹ÜÀíϵͳ
Ò©Îïɸѡ¹ÜÀíϵͳ
      
      ÐÂÒ©Ñо¿ÊôÓڸ߿Ƽ¼ÁìÓò,ÊÀ½ç¸÷¹ú¶ÔÐÂÒ©Ñо¿µÄͶÈëÖðÄêÔö¼Ó¡£¾Ýͳ¼Æ,1981ÄêÈ«ÊÀ½ç¶Ôr&dͶÈëΪ52ÒÚÃÀÔª,ÖÁ1996 ÄêÒÑ´ïµ½450ÒÚÃÀÔª¡£ËäÈ»ÐÂÒ©Ñо¿¿ª·¢µÄͶÈëÖðÄêÔö¼Ó,µ«Ã¿ÄêÉÏÊеÄеÄÒ»ÀàÐÂÒ©(nce)È´ÖðÄê¼õÉÙ,60Äê´ú³õÆÚ,ÿÄêÉÏÊеÄnceÔ¼100 ¸ö,1996Äê½ö40¸ö,Óɴ˿ɼû£¬Æ½¾ùÿһ¸öÐÂÒ©µÄ³É±¾Òà´ó·ù¶ÈµÄÔö¼Ó¡£
      ÈËÀà»ùÒò×é¼Æ»®µÄÍê³ÉÒÔ¼°ºóÐø¹¦ÄÜ»ùÒò×é(½á¹¹»ùÒò×é¡¢µ°°×ÖÊ×éºÍ´úл×éµÈ)¼Æ»®µÄʵʩ,Éî¿ÌµØ¸Ä±äÁËÒ©ÎïÑо¿ºÍ¿ª·¢µÄ˼·¼°²ßÂÔ,ÐγÉÁËÐÂÒ©Ñо¿µÄÐÂģʽ--´Ó»ùÒò×éµ½Ò©Îï(fromgenome to drug)£¬°üÀ¨Ð°бêµÄ·¢ÏÖÓëÈ·Ö¤¡¢Ïȵ¼»¯ºÏÎïµÄ·¢ÏÖÓëÓÅ»¯ÒÔ¼°Ò©Î↑·¢¡£ÆäÖУ¬Ïȵ¼»¯ºÏÎïµÄ·¢ÏÖ¹ý³ÌÖУ¬³£ÓõÄɸѡ·½Ê½ÓиßͨÁ¿É¸Ñ¡(high throughput screening£¬hts)ºÍÐéÄâɸѡ(virtual screening£¬vs)¡£

      ¸ßͨÁ¿É¸Ñ¡(high throughput screening£¬hts)¼¼ÊõÊÇÒÔ·Ö×ÓˮƽºÍϸ°ûˮƽµÄʵÑé·½·¨Îª»ù´¡£¬ÒÔ΢°åÐÎʽ×÷ΪʵÑ鹤¾ßÔØÌ壬ÒÔ×Ô¶¯»¯²Ù×÷ϵͳִÐÐÊÔÑé¹ý³Ì£¬ÒÔÁéÃô¿ìËٵļì²âÒÇÆ÷²É¼¯ÊµÑé½á¹ûÊý¾Ý£¬ÒÔ¼ÆËã»ú·ÖÎö´¦ÀíʵÑéÊý¾Ý£¬ÔÚͬһʱ¼ä¼ì²âÊýÒÔǧÍòµÄÑùÆ·£¬²¢ÒԵõ½µÄÏàÓ¦Êý¾Ý¿âÖ§³ÖÔËתµÄ¼¼ÊõÌåϵ£¬¼òÑÔÖ®¾ÍÊÇ¿ÉÒÔͨ¹ýÒ»´ÎʵÑé»ñµÃ´óÁ¿µÄÐÅÏ¢£¬²¢´ÓÖÐÕÒµ½ÓмÛÖµµÄÐÅÏ¢¡£

      µ«´«Í³µÄ¸ßͨÁ¿É¸Ñ¡Óöµ½Ðí¶àÎÊÌ⣬һÊÇÒ©Àí²âÊÔ¼ÙÑôÐÔÓë¼ÙÒõÐÔ½á¹û£»¶þÊÇ»¯ºÏÎïÑùÆ·À´Ô´¶Ìȱ£»ÈýÊÇͨÓÃÐÔ²»¸ß£¬ºÜ¶àhts·½·¨Ö»¶ÔÒ»ÖÖ»ò¼¸ÖÖø¾ßÓÐÊÊÓ¦ÐÔ£»Ëĺܶà¸ßͨÁ¿É¸Ñ¡·½·¨ÖÐËùÓõ½µÄÊÔ¼ÁºÍÒÇÆ÷¶¼·Ç³£°º¹ó£¬ºÜ¶àʵÑéÊÒ¶¼ÎÞ·¨Å䱸£¬¶øÓë´óÐÍÖÆÒ©ÆóÒµÏà±È£¬´ó²¿·Ö¿ÆÑе¥Î»Ã»ÓÐÕâÑùµÄ¾­¼ÃʵÁ¦¡£

      ÄÇÓÐʲô¸üΪ¸ßЧ¾­¼ÃµÄ°ì·¨ÄØ£¿ÇÒ¿´Ñо¿Ô±domanÈçºÎ½â¾ö£º

      domanµÈ[1]Ñо¿Ô±ÏëÑ°ÕÒiiÐÍÌÇÄò²¡°Ðµãµ°°×ÀÒ°±ËáÁ×Ëáõ¥Ã¸1b£¨ptp1b£©µÄÒÖÖƼÁ¡£Ê×ÏÈ£¬Ñо¿ÈËÔ±²ÉÓÃÁ˸ßͨÁ¿É¸Ñ¡µÄ·½·¨£¬Ö±½Ó½øÐÐÉúÎïѧ²âÊÔ£¬ÅúÁ¿É¸Ñ¡ÁË40Íò¸ö»¯ºÏÎµÃµ½ÁË6¸ö»îÐÔСÓÚ10¦ÌmµÄ»¯ºÏÎËæºóÑо¿ÈËÔ±²ÉÓÃÁËÐéÄâɸѡµÄ·½·¨£¬´Ó40Íò¸ö»¯ºÏÎïÔ¤²â²¢ÌôÑ¡³öÆäÖеÄ365¸ö»¯ºÏÎï½øÐÐÉúÎïѧ²âÊÔ£¬´Ó¶øµÃµ½21¸ö»îÐÔСÓÚ10¦ÌmµÄ»¯ºÏÎÁ½ÖÖ·½·¨µÄ½á¹ûÁÐÓÚͼ¡£´ÓÖпÉÒÔ¿´µ½£¬¾­¹ýÐéÄâɸѡºóÔÙ½øÐÐÉúÎïѧ²âÊÔ£¬Æä¡°ÃüÖÐÂÊ¡±±ÈËæ»úµÄ¸ßͨÁ¿É¸Ñ¡Ìá¸ßÁË400±¶¡£
µ±ÐéÄâɸѡÓöÉϸßͨÁ¿É¸Ñ¡
£¨ps£º¸ßͨÁ¿É¸Ñ¡ÓëÐéÄâɸѡÔÙÉúÎïѧ²âÊԵķ½·¨ÂÔÓв»Í¬£¬ÐéÄâɸѡÔÙÉúÎïѧ²âÊԵIJâÊÔÌõ¼þ²»°üÀ¨albumin£¬¹Êµ¼Ö½á¹ûÆ«¸ß£©

      ÉÏÊöÑо¿ËµÃ÷£¬ÐéÄâɸѡ·½·¨´ó´óÌá¸ßÒ©Îï·¢ÏֵĸÅÂÊ£¬²¢½µµÍÁËÑз¢³É±¾¡£ÄÇʲôÊÇÐéÄâɸѡÄØ£¿¡ª¡ªÐéÄâɸѡ(virtual screening£¬vs)ÊÇÖ¸»ùÓÚÒ©ÎïÉè¼ÆÀíÂÛ£¬½èÖú¼ÆËã»úµÄ¼¼ÊõºÍרҵӦÓÃÈí¼þ£¬´Ó´óÁ¿»¯ºÏÎïÖÐÌôÑ¡³öһЩÓÐÃçÍ·µÄ»¯ºÏÎ½øÐÐʵÑé»îÐÔÆÀ¼ÛµÄÒ»ÖÖ·½·¨¡£ÆäÄ¿µÄÊÇ´Ó¼¸Ê®¸öÄËÖÁ°ÙÍò¸ö·Ö×ÓÖÐɸѡ³öеÄÏȵ¼»¯ºÏÎï¡£ÕâÖÖÒ©Îïɸѡ·½Ê½²»ÏûºÄÑùÆ·£¬½µµÍÁËɸѡµÄ³É±¾£¬»¹¿¼ÂÇ»¯ºÏÎï·Ö×ÓÒ©¶¯Ñ§ÐÔÖʺͶ¾ÐÔ£¬Ôö¼ÓɸѡµÄÄÚº­¡£²¢ÇÒËõ¶ÌÁËÐÂÒ©Ñз¢ÖÜÆÚ£¬½µµÍÁËÖ±½ÓÑз¢·ÑÓã¬Ïà±ÈÓÚ¸ßͨÁ¿É¸Ñ¡£¬ÐéÄâɸѡ²»´æÔÚÑùÆ·ÏÞÖÆ¡£
µ±ÐéÄâɸѡÓöÉϸßͨÁ¿É¸Ñ¡-1

°®ÆÐÐÂÒ©Îïɸѡ¹ÜÀíϵͳ


      ÓÉ°®ÆÐÐÂÒ½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾¿ª·¢µÄÒ©Îïɸѡ¹ÜÀíϵͳÊÇÒ»¿î×ÛºÏÐéÄâɸѡÓëʵÌåɸѡµÄÒ©ÎïɸѡÊý¾Ý¹ÜÀíϵͳ£¬ÄÚÖû¯ºÏÎï×ÊÔ´¿â£¬Îª´ó¹æÄ£»¯ºÏÎï¸ßͨÁ¿É¸Ñ¡ÌṩÊý¾Ý¹ÜÀíһվʽ½â¾ö·½°¸£¬¼Ó¿ìÒ©Îï·¢ÏÖ£¬ÏµÍ³ÕûºÏÐéÄâɸѡ¡¢ÊµÌåɸѡ¼°»¯ºÏÎï×ÊÔ´Èý´óÄ£¿é£¬Êý¾ÝÏ໥¹ØÁª¡£»ùÓÚÏàËÆÐÔÔ­Àí£¬´Ó»¯ºÏÎï×ÊÔ´¿âÖвéÕÒÏàËÆ»¯ºÏÎ´Ó¶ø½øÐÐÉúÎïʵÑéÑéÖ¤£¬²¢½«É¸Ñ¡Êý¾Ýͨ¹ýʵÌåɸѡģ¿é¹ÜÀí£¬Ò»¸ö»îÐÔ»¯ºÏÎï·¢ÏÖ¶à¸ö»îÐÔ»¯ºÏÎʵÏÖһվʽ¿ÆÑÐÊý¾Ý¹ÜÀí¡£

Ëü¾ßÓÐÈçϹ¦ÄÜ£º
1¡¢Ò©ÎïÐéÄâɸѡ
Ìṩ¿ìËÙ¸ßЧµÄÒ©ÎïÐéÄâɸѡ¹¦ÄÜ£¬Ã¿Ãë¿Éɸѡ 20 Íò¸ö»¯Ñ§½á¹¹£»»ùÓÚ·Ö×Ó¶þάºÍÈýάÏàËÆÁ½ÖÖ·½·¨£¬Ò»¸ö»îÐÔ»¯ºÏÎï·¢ÏÖ¶à¸ö»îÐÔ»¯ºÏÎ¼ÓËÙÒ©Îï·¢ÏÖ£»Ò»¼üÌá½»£¬É¸Ñ¡¸ßЧ£¬Ëٶȿ죬ȫ³Ì¿É×·ËÝ¡£
µ±ÐéÄâɸѡÓöÉϸßͨÁ¿É¸Ñ¡-2
2¡¢Ò©ÎïʵÌåɸѡ
¶Ô»¯ºÏÎï¼°ÆäÉúÎï»îÐÔɸѡÊý¾Ý½øÐйÜÀí£¬Ö§³Ö·Ö×Óˮƽ¡¢Ï¸°ûˮƽ¡¢¶¯ÎïˮƽµÈ²»Í¬²ã´ÎÒ©ÎïɸѡµÄÊý¾Ý¹ÜÀí£»ÌṩҩÎïʵÌåɸѡÐÅÏ¢´æ´¢Óë²éѯģ¿é£¬¿ÉÁé»îÅäÖÃÏà¹ØÄ£¿éµÄ×Ö¶ÎÐÅÏ¢£¬½øÐÐʵÌåɸѡÐÅÏ¢µÄ±ã½Ý´æ´¢Óë¿ìËÙ²éѯ¡£
µ±ÐéÄâɸѡÓöÉϸßͨÁ¿É¸Ñ¡-3
3¡¢»¯ºÏÎï×ÊÔ´¿â
ÄÚÖû¯ºÏÎï×ÊÔ´¿â£¬°üÀ¨Ò©Îï¿â£¬ÌìÈ»²úÎï¿â£¬ºÏ³É»¯ºÏÎï¿âµÈ£¬ÎÞ·ì¶Ô½Ó»¯ºÏÎ﹩ӦÉÌ£¬ÎªÓû§¹ºÂò»¯ºÏÎïÌṩ±ã½Ý·þÎñ£»Ò²Ö§³Ö¹ÜÀí±¾µØ»¯ºÏÎï×ÊÔ´¿â¡£

4¡¢ÍŶӹÜÀí
ÍŶÓÓÉ´´½¨ÈË´´½¨£¬ÍŶӳÉÔ±ÓɹÜÀíÔ±´´½¨²¢Í³Ò»¹ÜÀí£»ÍŶÓ×ÊÔ´¼°ÆäɸѡÐÅÏ¢ÓÉÍŶÓͳһ¹ÜÀí£¬È¨ÏÞ·ÖÃ÷£¬Êý¾Ý°²È«¡£

¼¼ÊõÓÅÊÆ
1£©Ò©Îïɸѡ¹ÜÀíϵͳºËÐļ¼Êõ»ùÓÚ·Ö×ÓÈýάÐÎ×´µþºÏËã·¨£¨wega£©ÒÑ»ñµÃÃÀ¹úרÀûÊÚȨ£¨us 9,811,642 b2£©£¬yan, x.µÈ[2]·¢±íµÄÎÄÕÂÖ¤Ã÷Æ侫¶È¸ßÓÚͬÀàËã·¨£»
2£©ËüÊǼ¯ÐéÄâɸѡÓëʵÌåɸѡÊý¾Ý¹ÜÀíÓÚÒ»Ì壬ʵÏÖin silico£¬in vitro£¬in vivoÒ©ÎïɸѡÊý¾Ý¹ÜÀí£¬ÌṩҩÎïɸѡһվʽ·þÎñ£»
3£©·½±ã¹ÜÀíÓëЭ×÷£¬Ö§³ÖÉè¼Æ¡¢ºÏ³É¡¢ÉúÎïµÈ¶àÍŶÓЭ×÷£¬Êý¾Ý¹²Ïí£¬È¨ÏÞ·ÖÃ÷£»
4£©Êý¾Ý°²È«£¬²ÉÓÃ×îеÄÊý¾Ý¼ÓÃܼ¼Êõ£¬Õ˺ŵǼ£¬È¨ÏÞ¿ØÖÆ£¬È«·½Î»±£ÕÏÊý¾Ý°²È«£»
5£©Ïà¶Ô¹úÍâ²úÆ·£¬½çÃæÇåÎú£¬·ûºÏ¹úÈËʹÓÃÏ°¹ß£»
6£©¹ú²ú×ÔÖ÷¿ª·¢£¬±ÜÃâ¼¼Êõ·âËø£¨Ä㶮µÄ£©¡£

ÐéÄâɸѡ×÷Ϊ¼ÆËã»ú¸¨ÖúÒ©ÎïÉè¼ÆÖеÄÒ»ÏîʵÓû¯¼¼Êõ£¬ÔÚµ±´úµÄ´´ÐÂÒ©ÎïÑз¢Öз¢»Ó×ÅÖØÒªµÄ×÷Ó᣶øÈô˵ҩÎïÉè¼ÆÕýÔÚ·¢Õ¹ÖУ¬ÄÇÒ©Îïɸѡ¹ÜÀíϵͳ¾ÍÊǸøËüÌáËٶȣ¬ËüÄÒÀ¨ÁËÐéÄâɸѡºÍʵÌåɸѡÊý¾Ý¹ÜÀí£¬×éÖ¯ÑϽ÷£¬È¨ÏÞÃ÷È·£¬½ÇÉ«·ÖÃ÷£¬´ó´óÌá¸ßÒ©ÎïɸѡЧÂÊ£¬¼Ó¿ìÐÂÒ©Ñз¢¡£
²Î¿¼ÎÄÏ×
[1]t.n.doman,et al.,molecular docking and high-throughput screening for novel inhibitors ofprotein tyrosine phosphatase-1b. journal of medicinal chemistry, 2002, 45: 2213-21
[2]yan, x.et al., enhancing molecular shape comparison by weighted gaussian functions.journal of chemical information and modeling 2013, 53, (8), 1967-78

ϵͳ·ÃÎÊÍøÖ·  http://demo.dsms.iprexmed.com/#/index
ϵͳ¿ªÍ¨ÇëÁªÏµ¿Í·þ
΢ÐÅ 18928913950
qq  2277165792
µç»° 020-28100562
µ±ÐéÄâɸѡÓöÉϸßͨÁ¿É¸Ñ¡-4
΢ÐÅ¿Í·þ

[ last edited by kspm20225 on 2018-12-17 at 11:05 ]

[ Last edited by kspm20225 on 2019-6-18 at 19:06 ]

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

» ²ÂÄãϲ»¶

» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:

²é¿´È«²¿É¢½ðÌù

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¡ï
kspm20225(½ð±Ò+1): лл²ÎÓë
29Â¥2019-06-11 16:04:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌøת ÎÒÒª¶©ÔÄÂ¥Ö÷ kspm20225 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍƼö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[»ù½ðÉêÇë] È¥ÄêÉêÇë»ù½ðµÄÆÀÉóÒâ¼ûÊÇChatGPTÔÚ¹úÄÚÊǽûÖ¹µÄ£¬Ñо¿·½°¸ÖÐÓÐʹÓÃChatGPT²»ºÏÀí +4 ˲ϢÓîÖæ 2024-05-19 4/200 2024-05-21 00:37 by dxcharlary
[˶²©¼ÒÔ°] ±»µ¼Ê¦×¥×ÅÒ»¸öÈìÑòë¸ÃÕ¦°ì +13 δÀ´¿ÉÆÚ¼òÖ±²»¶ 2024-05-15 25/1250 2024-05-20 23:03 by ca0yan9
[½Ìʦ֮¼Ò] ÇཷµÄδÀ´ÔÚÄÄÀ +17 sxhuabin 2024-05-15 18/900 2024-05-20 22:55 by ˲ϢÓîÖæ
[Óлú½»Á÷] ³ýDMSO +5 Spiralup 2024-05-15 6/300 2024-05-20 17:49 by ÁõºéÕñ
[½Ìʦ֮¼Ò] °×Ìì²»¶®Ò¹µÄºÚ£¬90ºóÇཷÓë60ºóÀÏ°å +4 zylfront 2024-05-18 5/250 2024-05-20 15:58 by xiaoyucau
[»ù½ðÉêÇë] ÊýÀíѧ²¿º¯ÆÀ¼¸ºÅ½áÊø£¿ +6 ¿ÆÑйÂÓÂÕß 2024-05-16 7/350 2024-05-20 09:05 by 6543yes
[½Ìʦ֮¼Ò] À´ÓÃÇ×ÉíÌå»á£¬Ò»Æð˵˵ÄêÇáÀÏʦµÄÐÁ¿à +19 zylfront 2024-05-17 25/1250 2024-05-19 16:19 by otani
[ÂÛÎÄͶ¸å] Nano-Micro LettersͶ¸å¿ÉÒÔÓÃPDFÉÏ´«Âð 5+4 962511369 2024-05-18 4/200 2024-05-19 15:47 by ca0yan9
[ÂÛÎÄͶ¸å] ÍƼöתͶ£¨ transfer pending£©ÊÇ·ñÓÐÓã¿ 50+3 lily5289 2024-05-17 7/350 2024-05-19 15:11 by wanghuawei
[ÂÛÎÄͶ¸å] ÇóÆÚ¿¯ÍƼö 30+3 jxhx666666 2024-05-15 6/300 2024-05-19 07:31 by ÆÚ¿¯·¢±í רÖø³ö
[˶²©¼ÒÔ°] Ä͸ßεæƬÇó¹º +6 Sexyflea 2024-05-16 9/450 2024-05-18 08:31 by nanbeiY
[½Ìʦ֮¼Ò] ΪºÎÒ»·½Ãæ¹úÄÚ´óѧ½ÌʦÎÞЧÄÚ¾í¹ýÀÍÊÅÊÀ£¬¶øÁíÒ»·½Ãæ¹ú¼ÒÈ´ÔÚÓ²ºË¿Æ¼¼Éϱ»¿¨²±×ÓÉîÖØ +16 zju2000 2024-05-15 20/1000 2024-05-18 07:28 by llhljsy
[ÂÛÎÄͶ¸å] µ±Ç°scientific reports»¹ÖµµÃͶ¸åô£¿ +5 lizhengke06 2024-05-14 6/300 2024-05-17 18:28 by dxcharlary
[»ù½ðÉêÇë] Çà»ù +3 ±ä³É³¬ÈË 2024-05-15 4/200 2024-05-17 12:42 by ssxclkj
[˶²©¼ÒÔ°] ÎåÂÈ»¯îêÔõôÈܽⰡ +3 ÄÏÄÏÖ¦Ö¦ 2024-05-17 5/250 2024-05-17 11:37 by ad_fish
[˶²©¼ÒÔ°] ÁìÑøСº¢ +15 Yyds55 2024-05-14 15/750 2024-05-17 09:53 by ÌïÔ°1983
[ÂÛÎÄͶ¸å] ÊÖ¸åÌá½»ÁËÁ½±é 10+3 Ñõ»¯»¹Ô­¼Á 2024-05-14 4/200 2024-05-16 22:43 by nono2009
[½Ìʦ֮¼Ò] Ëο­ +10 yexuqing 2024-05-14 10/500 2024-05-16 09:21 by shl2112501
[½Ìʦ֮¼Ò] ÎÊÌâÒѽâ¾õ£¬Ð»Ð»´ó¼Ò¹Ø×¢£¡ +7 lzgj258 2024-05-15 11/550 2024-05-15 19:15 by »·¾³¼ì²â2024
[ÂÛÎÄͶ¸å] Æ߸öÔÂÁË£¬»¹ÔÚselecting for review +3 g9522 2024-05-14 6/300 2024-05-14 19:00 by lizhengke06
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û